Macular Degeneration Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are 18 years old or older, male or female, and have been diagnosed with the "wet" (exudative) form of age-related macular degeneration (AMD).
• You have been receiving eye injections of either ranibizumab or aflibercept for more than 1 year to treat your condition.
• Your eye injections are currently needed more frequently than every 12 weeks (i.e., your injection intervals are shorter than 12 weeks).

Who may not be able to join:

• You have severe short-sightedness, defined as having an eye length greater than 26 mm or a glasses prescription lower than -6 dioptres.
• You have a condition called angioid streaks (crack-like lines in the back of the eye).
• You have moderate or severe diabetic retinopathy (eye damage caused by diabetes).
• You have a history of diabetic macular oedema (fluid build-up in the eye related to diabetes).
• You have a history of uveitis (inflammation inside the eye).
• You have previously had a retinal vein occlusion (a blockage of a blood vessel in the back of the eye).
• You have a history of a condition called pseudovitelliform macular dystrophy (a rare inherited eye disorder — confirm with trial site if unsure).
• You are currently under legal guardianship or trusteeship.
• You are pregnant or currently breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.